Peregrine Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-157,671
Closed -$6.96M 343
2025
Q1
$6.96M Sell
157,671
-3,515
-2% -$162K 0.23% 124
2024
Q4
$5.82M Sell
161,186
-4,348
-3% -$152K 0.17% 188
2024
Q3
$5.3M Buy
165,534
+28,971
+21% +$1.08M 0.16% 208
2024
Q2
$5.14M Buy
136,563
+19,915
+17% +$838K 0.15% 226
2024
Q1
$5.74M Sell
116,648
-19,361
-14% -$895K 0.16% 214
2023
Q4
$4.96M Sell
136,009
-23,469
-15% -$613K 0.15% 228
2023
Q3
$3.69M Sell
159,478
-10,015
-6% -$274K 0.11% 239
2023
Q2
$4.44M Sell
169,493
-50
-0% -$1.31K 0.12% 244
2023
Q1
$4.36M Buy
169,543
+5,002
+3% +$146K 0.13% 241
2022
Q4
$4.28M Buy
+164,541
New +$4.05M 0.13% 239

Other funds holding SWTX